Written by Dr Ian Z. Chuang, global Chief Medical Officer, Elsevier EMEALAAP Health
In these unprecedented times, technology’s ability to mine and analyse research and medical data and access digital data on a global scale can play a vital role in helping public health authorities, researchers and clinicians to contain and manage COVID-19’s rapid progression.
That’s why Elsevier is taking steps to grant access to some of our industry-leading tools and resources.
COVID-19 Information Centre
Our COVID-19 Information Centre was made available very early on as the pandemic became clear, and contains expert, curated information in English and Mandarin on SARS-CoV-2 (the novel coronavirus) and COVID-19 (the disease).
The site packages all the latest research and resources on the virus and provides it without copyright limitations to interested parties. It also features an interactive global map of experts based on Scopus data, guidelines for clinicians and patients, and a series of podcasts in which experts share their insights into the mode of transmission and pathophysiology of COVID-19, how medical informatics and telemedicine can be used to manage it, and best practices for emergency nursing crisis preparedness.
Researchers are already accessing the hub to keep pace with the growing body of literature on the pandemic, and to search for trends that could ultimately help inform governmental responses and the development of vaccines. We’ve pledged it will remain open until the public health emergency abates.
COVID-19 Clinical Toolkit
To help support NHS clinicians working on the front line - and their patients - the Elsevier COVID-19 Clinical Toolkit is now freely available.
It includes staff education resources - such as eLearning modules, drug monographs and concise overviews – and clinical Order Sets and Care Plans, as well as patient information in the form of handouts and videos.
It’s our hope that the toolkit can help reduce variation in care across the country and minimise administrative workload on healthcare providers - since the content is pre-built and updated based on current knowledge, the material is ready for immediate use, and saves users the time and resources needed to build, manage and maintain content themselves.
Support for clinical researchers
Finally, to assist researchers working to develop vaccines and other therapies for COVID-19, we have taken the decision to make our VeridataTM software solution available via a free 12-month license.
This next-generation Electronic Data Capture platform provides a secure, compliant and user-friendly way of capturing and streamlining data collection and facilitating workflows.
At a time when researchers around the globe are uniting to fight COVID-19, we felt it was our duty to stand alongside them and offer a means to quickly and easily identify new insights.
We’re in this together
As a member of the research and health community, Elsevier will continue to support healthcare professionals, educators, clinical researchers and policy makers during these challenging times. In addition to the above resources, we are also swiftly updating our COVID-19-related knowledge and making it available to all of our customers across solutions such as STATdx – our diagnostic imaging decision support tool.
There’s no doubt that we’re not just a nation at war with COVID-19, but a world. We’re therefore proud to be in a position where we can play a part: by enabling efficient data sharing and empowering clinicians to set standards of care early on, we hope to do our bit to facilitate scientific breakthrough and improve patient outcomes going forward.